54 related articles for article (PubMed ID: 15099967)
21. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
Strickler HD; Burk RD; Fazzari M; Anastos K; Minkoff H; Massad LS; Hall C; Bacon M; Levine AM; Watts DH; Silverberg MJ; Xue X; Schlecht NF; Melnick S; Palefsky JM
J Natl Cancer Inst; 2005 Apr; 97(8):577-86. PubMed ID: 15840880
[TBL] [Abstract][Full Text] [Related]
22. Synergy between cigarette smoking and human papillomavirus type 16 in cervical cancer in situ development.
Gunnell AS; Tran TN; Torrång A; Dickman PW; Sparén P; Palmgren J; Ylitalo N
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2141-7. PubMed ID: 17057029
[TBL] [Abstract][Full Text] [Related]
23. [Cervical cancer prevention: the impact of HPV vaccination].
Monsonégo J
Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
[TBL] [Abstract][Full Text] [Related]
24. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys.
Vaccarella S; Herrero R; Dai M; Snijders PJ; Meijer CJ; Thomas JO; Hoang Anh PT; Ferreccio C; Matos E; Posso H; de Sanjosé S; Shin HR; Sukvirach S; Lazcano-Ponce E; Ronco G; Rajkumar R; Qiao YL; Muñoz N; Franceschi S
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2148-53. PubMed ID: 17119039
[TBL] [Abstract][Full Text] [Related]
25. [Oral contraceptive and the increased risk of cervical cancer].
Heikinheimo O; Leminen A
Duodecim; 2003; 119(24):2405-6. PubMed ID: 14870500
[No Abstract] [Full Text] [Related]
26. Risk factors for cervical carcinoma: does detection bias play a role?
Slattery ML; Gardner JW
Epidemiology; 1991 Jul; 2(4):293-6. PubMed ID: 1912046
[TBL] [Abstract][Full Text] [Related]
27. [So-called groups of women "at risk" for cervical cancer morbidity].
Charkviani LI
Vopr Onkol; 1973; 19(12):91-4. PubMed ID: 4274440
[No Abstract] [Full Text] [Related]
28. Oral contraceptives and cervical cancer.
Berrington A; Jha P; Peto J; Green J; Hermon C;
Lancet; 2002 Aug; 360(9330):410. PubMed ID: 12241800
[No Abstract] [Full Text] [Related]
29. Past, present and future of the cervical cancer screening in Latvia.
Viberga I; Engele L; Baili P;
Tumori; 2010; 96(4):529-37. PubMed ID: 20968131
[TBL] [Abstract][Full Text] [Related]
30. [The probability of becoming ill with malignant neoplasms over the space of the prospective life span for the population of the Latvian SSR].
Aksel' EM; Dvoĭrin VV; Militosian NA; Suveĭzde RB
Vopr Onkol; 1989; 35(11):1294-300. PubMed ID: 2609516
[No Abstract] [Full Text] [Related]
31. [Certain indices of the peripheral blood of the population of the Latvian SSR].
Iashanova ND; Zaĭtseva MV; Ponomareva NG; Terebkova ZF
Lab Delo; 1970; 1():16-8. PubMed ID: 4192168
[No Abstract] [Full Text] [Related]
32. [Experience with tuberculosis control in Daugavpils in the Latvian SSR].
Ivanov DA; Rudovskiĭ ST
Probl Tuberk; 1965; 43(1):12-6. PubMed ID: 5832060
[No Abstract] [Full Text] [Related]
33. [CURRENT STATUS OF CANCER CONTROL IN LATVIA].
BRAMBERGA VM
Klin Lech Zlokach Novoobraz; 1963; 92():5-9. PubMed ID: 14182330
[No Abstract] [Full Text] [Related]
34. An overview of cervical cancer epidemiology and prevention in the Baltic States.
Kojalo U; Tisler A; Parna K; Kivite-Urtane A; Zodzika J; Stankunas M; Baltzer N; Nygard M; Uuskula A
BMC Public Health; 2023 Apr; 23(1):660. PubMed ID: 37029357
[TBL] [Abstract][Full Text] [Related]
35. Molecular Epidemiology of High-Risk Types of Human Papillomaviruses (16, 18) in Pap-Smear, the North East of Iran.
Moradi A; Bakhshandeh Nosrat S; Besharat S
Iran J Cancer Prev; 2011; 4(3):135-40. PubMed ID: 26328053
[TBL] [Abstract][Full Text] [Related]
36. PARP-1 Val762Ala polymorphism is associated with risk of cervical carcinoma.
Ye F; Cheng Q; Hu Y; Zhang J; Chen H
PLoS One; 2012; 7(5):e37446. PubMed ID: 22624032
[TBL] [Abstract][Full Text] [Related]
37. Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia.
Uusküla A; Kals M; Kosenkranius L; McNutt LA; DeHovitz J J
BMC Infect Dis; 2010 Mar; 10():63. PubMed ID: 20222944
[TBL] [Abstract][Full Text] [Related]
38. A population-based study of cervical carcinoma and HPV infection in Latvia.
Silins I; Wang X; Tadesse A; Jansen KU; Schiller JT; Avall-Lundqvist E; Frankendal B; Dillner J
Gynecol Oncol; 2004 May; 93(2):484-92. PubMed ID: 15099967
[TBL] [Abstract][Full Text] [Related]
39. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.
Shields TS; Brinton LA; Burk RD; Wang SS; Weinstein SJ; Ziegler RG; Studentsov YY; McAdams M; Schiffman M
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1574-82. PubMed ID: 15466972
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
